期刊文献+

辛伐他汀在人、食蟹猴和大鼠血浆中稳定性的种属差异

Species-related Stability Difference of Simvastatin in Human,Cynomolgus Monkey and Rat Plasma
原文传递
导出
摘要 目的 建立LC—MS/MS法测定辛伐他汀在食蟹猴血浆中的检测方法学,并比较其在人、食蟹猴和大鼠3种动物血浆中的稳定性差异。方法建立LC—MS/MS分析食蟹猴血浆辛伐他汀药物浓度的方法学;配制辛伐他汀3种动物血浆样品,分别于室温放置4h、24h及-80℃冻存1个月,并定量检测。结果辛伐他汀线性范围为0.5~50μg·L^-1,定量下限为0.5μg·L^-1,相对回收率99~109%,日内、日间精密度均小于6.67%;辛伐他汀在食蟹猴血浆中室温放置24h样品的药物浓度降低70%左右;在SD大鼠血浆中室温放置4h和24h样品的药物浓度分别降低75%和80%左右;在人血浆中室温放置24h的样品的药物浓度降低30%左右;-80℃冻存条件下,除大鼠血浆样品外,其他样品基本稳定。结论所建立的方法适用于小体积实验动物辛伐他汀药动学研究;辛伐他汀在不同动物种属血浆中的稳定性存在很大差异。 OBJECTIVE To establish an LC-MS/MS method for the determination of simvastatin in eynomolgus monkey plasma, and compare its stability differences in three species of human, eynomolgus monkey and rat plasma. METHODS Validated LC-MS/ MS method was established and used for analysis of simvastatin samples which were prepared in the plasma of three species and stored under different conditions. RESULTS The linearity of calibration curve was 0.5-50μg·L^-1 and the limit of quantitation was 0.5 μg·L^-1. The inter- and inner- day precision were below 6.67% and the accuracy of the method was 99-109%. Drug concentration of cynomolgus monkey plasma samples being placed 24 h at room temperature decreased 70% , drug concentration of SD rat plasma samples being placed 4 h and 24 h at room temperature decreased 75% and 80% ,drug concentration of human plasma samples being placed 24 h at room temperature decreased 30%. Samples frozen at - 80℃ were mostly stable, except for that of rat plasma samples. CONCLUSION The established method is suitable for the determination of simvastatin in cynomolgus monkey plasma. Stability of simvastatin varies greatly in different plasma and shows species-related differences.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第4期261-264,共4页 Chinese Journal of Modern Applied Pharmacy
基金 国家高技术研究发展(863)计划(2006AA02Z339) 广州市科技局(2006Z1-E4031) 广州经济技术开发区(2006Ss-P067)资助项目
关键词 辛伐他汀 血浆稳定性 种属差异 LC—MS/MS simvastatin plasma stability species difference LC-MS/MS
  • 相关文献

参考文献11

  • 1BROWN M S,GOLDSTEIN J L. A receptor-mediated pathway for cholesterol homeostasis [ J ]. Science, 1986, 232 (4746) :34-47.
  • 2HOEG J M, BREWERrewer HB Jr. 3-Hydroxy-3-methylglutarylcoenzyme A reductase inhibitors in the treatment of hypercholesterolemia[J].JAMA, 1987, 258 (24) : 3532-3536.
  • 3Christopher-Stine L. Statin myopathy: an update [J]. Curt Opin Rheumatol,2006,18 ( 6 ) :647 4553.
  • 4ANTONS KA, WILLIAMS CD, BAKER SK, et al. Clinical perspectives of statin-induced rhabdomyolysis [ J ]. Am J Med, 2006, 119(5) : 400-409.
  • 5石萍,陈相潘.辛伐他汀口腔崩解片的人体生物等效性研究[J].中国药房,2007,18(35):2757-2759. 被引量:6
  • 6冯芳,田勇,戴惠.辛伐他汀咀嚼片的人体药代动力学和相对生物用度[J].中国临床药理学杂志,2002,18(6):441-444. 被引量:9
  • 7翁静艳,杭太俊,顾洁,吴晓鸾,甘春,杨林,文爱东.液相色谱-串联质谱法测定辛伐他汀片的人体药动学和生物等效性[J].中国新药与临床杂志,2007,26(5):347-351. 被引量:10
  • 8BERGMAN M, SALMAN H, DJALDETYI M,et al. Uhrastructure of mouse striated muscle fibers following pravastatin administration [ J ]. J Muscle Res Cell Motil, 2003,24 ( 7 ) : 417- 420.
  • 9SMITH PF, EYDELLOTH RS, GROSSMAN SJ, et al. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies [ J ]. J Pharmacol Exp Ther, 1991,257 (3) : 1225-1235.
  • 10SONODA Y, GOTOW T, KURIYAMA M, et al. Electrical myotonia of rabbit skeletal muscles by HMG-CoA reductase inhibitors [ J ]. Muscle Nerve, 1994,17 ( 8 ) :891-897.

二级参考文献18

  • 1俞进.降胆固醇新药──胆固醇合成抑制剂[J].首都医学院学报,1995,16(1):80-81. 被引量:7
  • 2Endo A, Kuroda M,Tsuhita Y. ML-236A, ML-236B, and ML236C, new inhibitors of cholesterogenesis produced by peniciuium citrinum, J Antibiot, 1976;29:1346~1348.
  • 3Hisao O, Naotaka U, Kazuhode I, et al. Determination of simvastatin and its active metabolite in human plasma by columnswitching high-performance liquid chromatography with fluorescence detection after derivatization with lbromoacetylpyrene. J Chromatogr B, 1997(694):211~217.
  • 4Endo A, Hasumi K, Tsuhita Y, Momacolins J, et al., new inhibitors of cholesterol biosynthesis produced by monascus rubber, J Antibiot,1985 ;38:420~422.
  • 5Kakano T, Abe S, Hata S.A selected ion monitoring method for quantifying simvastatin and its acid form inhuman plasma using the ferroceneboronate derivative. Biomed. Environ. Mass Spectrom,1990;19:577~581.
  • 6Morris MJ, Gilbert JD, Hiseh JYK. et, al. Determination of the HMG-CoA reductase inhibitors simastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry. Mass Spectr, 1993 ;22:1~8.
  • 7Mauro V F. Clinical pharmacokinetics and practical applications of simvatatin. Clin Pharmacokin, 1993;24:195~202.
  • 8ZHANG N,YANG A,ROQERS JD,et al.Quantitative analysis of simvastatin and its β-hydroxy acid in human plasma using automated liquid-liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry[J].J Pharm Biomed Anal,2004,34(1):175-187.
  • 9孙春华,李三鸣,刘蕾,赫广威,史爱欣,李可欣.国产辛伐他汀片剂人体生物利用度研究[J].中国临床药理学杂志,1999,15(6):431-434. 被引量:10
  • 10王素如,李凤阁.辛伐他汀与洛伐他汀治疗高脂血症疗效比较[J].中国新药与临床杂志,2000,19(4):264-266. 被引量:11

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部